University of Texas Southwestern Medical Center: clinical-trial pipeline
University of Texas Southwestern Medical Center is the sponsor of 1,006 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 240 are not yet finished and 9 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 591 |
| Phase 2 | 132 |
| Phase 4 | 109 |
| Phase 1 | 61 |
| Phase 1/2 | 37 |
| Early phase 1 | 33 |
| Phase 3 | 31 |
| Phase 2/3 | 12 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 547 |
| Recruiting | 164 |
| Terminated | 110 |
| Withdrawn or not authorised | 105 |
| Active, not recruiting | 39 |
| Not yet recruiting | 37 |
| Suspended or halted | 3 |
| Unknown | 1 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 243 |
| Cardiovascular | 140 |
| Metabolic and endocrine (diabetes, obesity) | 115 |
| Psychiatry and mental health | 101 |
| Nephrology and urology | 77 |
| Neurology | 69 |
| Gastroenterology and liver | 62 |
| Rare and genetic diseases | 61 |
| Infectious disease and vaccines | 48 |
| Respiratory | 48 |
| Women's health and obstetrics | 33 |
| Dermatology | 27 |
Countries
| Country | Trials |
|---|---|
| United States | 939 |
| Canada | 3 |
| United Kingdom | 2 |
| Australia | 1 |
| Japan | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-21 | New trial posted | Pragmatic Interventions to Advance Cancer Survivor Outcomes |
| 2026-10-21 | New trial posted | Deep Brain Stimulation Guided by Brain Mapping to Treat Cognitive Impairment |
| 2026-10-16 | New trial posted | Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular Carcinoma |
| 2026-10-05 | New trial posted | Food Introduction for Risk Reduction, Support Tolerance: Behavioral Intervention for Todd… |
| 2026-09-30 | New trial posted | Walk Together Efficacy Trial |
| 2026-09-17 | New trial posted | Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder |
| 2026-08-27 | New trial posted | The Effects of a Caregiver-initiated Reading Intervention to Their Infant in the Neonatal… |
| 2026-08-26 | New trial posted | Tailored Neoadjuvant Chemoimmunotherapy for Stage I TNBC |
| 2026-08-26 | New trial posted | Sensory and Physical Reactions to Beverage Cues |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT07704775 | Nemolizumab for LS | Phase 2 | Not yet recruiting | United States |
| NCT06044857 | PSMA PET Response Guided SabR in High Risk Pca | Phase 1 | Recruiting | United States |
| NCT02919280 | Dallas 2K: A Natural History Study of Depression | Not applicable | Active, not recruiting | United States |
| NCT05825950 | Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC) | Not applicable | Recruiting | United States |
| NCT07223242 | Tailored Exercise Training Study Among Adults With HFpEF | Phase 2/3 | Recruiting | United States |
| NCT07361874 | IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion | Not applicable | Recruiting | United States |
| NCT01409109 | Database Registry for Neural Network Biomarkers in Psychosis | Not applicable | Recruiting | United States |
| NCT07721272 | Human Cognition During Surgery: Stimulation-based and Cholinergic Modulation | Early phase 1 | Not yet recruiting | United States |
| NCT07430761 | ET Stigma Response to Tremor Suppression | Not applicable | Recruiting | United States |
| NCT06789848 | Ligufalimab and Cadonilimab in Advanced Liver Cancers | Phase 2 | Recruiting | United States |
| NCT06907199 | Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tr… | Phase 1 | Recruiting | United States |
| NCT02353819 | Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer | Phase 1 | Active, not recruiting | United States |
| NCT05625191 | Patients With and Without Phonotrauma | Not applicable | Recruiting | United States |
| NCT06712745 | Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers… | Early phase 1 | Recruiting | United States |
| NCT05576974 | A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an… | Phase 2 | Recruiting | United States |
| NCT06076538 | PET/MR for Characterization of Renal Masses (RMs) | Not applicable | Recruiting | United States |
| NCT07622927 | FOCUS Bipolar: Families Opening Conversations for Understanding Signs | Not applicable | Recruiting | United States |
| NCT07878689 | Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular Carcinoma | Phase 1/2 | Not yet recruiting | United States |
| NCT04829110 | Alcohol Induced de Novo Lipogenesis in Women | Not applicable | Active, not recruiting | United States |
| NCT04572321 | Youth Depression and Suicide Research Network | Not applicable | Recruiting | United States |
| NCT05145816 | Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis | Phase 1/2 | Recruiting | United States |
| NCT05319015 | Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus | Phase 2 | Recruiting | United States |
| NCT05730582 | Increasing Uptake of EHR-enabled Population Health Outreach Strategies to Improve Diabetes Screening | Not applicable | Recruiting | United States |
| NCT07352709 | Ventilation Performance and Feedback Simulation Trial | Not applicable | Recruiting | United States |
| NCT07313241 | Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Earl… | Phase 2 | Recruiting | United States |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "University of Texas Southwestern Medical Center clinical trials: 240 open, 43 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/university-of-texas-southwestern-medical-center/, data as of 2026-10-25.